These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3135129)

  • 1. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
    Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction between fibronectin and aggregated IgG].
    Menzel EJ; Borth W; Kaik B
    Wien Klin Wochenschr; 1983 Dec; 95(24):880-4. PubMed ID: 6608184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the incorporation of fibronectin into synovial fluid cryoprotein.
    Carsons S; Lavietes BB; Diamond HS
    J Lab Clin Med; 1983 Nov; 102(5):722-31. PubMed ID: 6605399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of C1q with beta 2-microglobulin.
    Björck L; Johnson U; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
    Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
    Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
    Niven IP; Whaley K
    Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
    Menzel J; Steffen C
    Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of the binding site in subcomponent C1q for plasma fibronectin.
    Reid KB; Edmondson J
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():11-7. PubMed ID: 6610277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions between collagen and C1q: their significance for rheumatology].
    Menzel EJ
    Z Rheumatol; 1980; 39(7-8):251-83. PubMed ID: 7006253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic alteration of C1q, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen.
    Heinz HP; Brackertz D; Loos M
    FEBS Lett; 1988 Feb; 228(2):332-6. PubMed ID: 2830144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin binding with immunoglobulin aggregates and its association with rheumatic disorders.
    Carter SD; Scott DL; Elson CJ
    Br J Rheumatol; 1986 Nov; 25(4):353-8. PubMed ID: 3490895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
    Bratt T; Ohlson S
    J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form.
    Carsons S; Lavietes BB; Slomiany A; Diamond HS; Berkowitz E
    J Clin Invest; 1987 Nov; 80(5):1342-9. PubMed ID: 3680500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for the binding of human plasma fibronectin to the C1q subunit of the first component of complement.
    Sorvillo J; Gigli I; Pearlstein E
    J Immunol; 1983 Sep; 131(3):1400-4. PubMed ID: 6309962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.